Back
Fulcrum Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison
Sell
1
FULC
Fulcrum Therapeutics
Last Price:
3.46
Seasonality Move:
-0.93%
Sell
37
TRDA
Entrada Therapeutics
Last Price:
15.02
Seasonality Move:
13.84%
Sell
1
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.44. The Score for FULC is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $13.66. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight selling pressure.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $13.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.
FULC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.33 | Sell |
Relative Strength Index (14 RSI): | 24.25 | Sell |
Chaikin Money Flow: | -65859 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.54 - 10.08) | Sell |
Bollinger Bands (100): | (6.37 - 9.11) | Sell |
TRDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 34.17 | Sell |
Chaikin Money Flow: | -107441 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.74 - 16.8) | Sell |
Bollinger Bands (100): | (14.08 - 16.6) | Sell |
FULC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.33 | Sell |
20-day SMA: | 7.42 | Sell |
50-day SMA: | 8.19 | Sell |
200-day SMA: | 7.89 | Sell |
8-day EMA: | 4.87 | Sell |
20-day EMA: | 6.61 | Sell |
50-day EMA: | 7.59 | Sell |
200-day EMA: | 7.49 | Sell |
TRDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.6 | Sell |
20-day SMA: | 15.61 | Sell |
50-day SMA: | 15.96 | Sell |
200-day SMA: | 14.67 | Sell |
8-day EMA: | 14.57 | Sell |
20-day EMA: | 15.2 | Sell |
50-day EMA: | 15.49 | Sell |
200-day EMA: | 14.99 | Sell |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.15 per share, an increase this year of $1.40 per share, and a decrease next year of $0.79 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Fulcrum Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Entrada Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |